Alpha DNA Investment Management’s RPC Inc RES Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-124,913
Closed -$1.11M 195
2022
Q4
$1.11M Buy
+124,913
New +$1.13M 0.39% 71
2022
Q2
Sell
-117,134
Closed -$1.25M 161
2022
Q1
$1.25M Buy
+117,134
New +$935K 0.88% 41

Other funds holding RES

Alpha DNA Investment Management's RES Position: Q1 2023 in Review

Alpha DNA Investment Management sold out of RPC Inc (RES) in Q1 2023, closing a stake of 124,913 shares — an estimated $1.11M sold.

Alpha DNA Investment Management first reported a position in RES in Q1 2022 and held it in 2 quarters. The position peaked at $1.25M in Q1 2022. 229 funds tracked by Wall St. Rank hold RES as of Q1 2023.

  • Alpha DNA Investment Management reported no remaining RPC Inc position as of Q1 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 124,913 RPC Inc shares in Q1 2023, an estimated $1.11M.
  • Alpha DNA Investment Management first reported a position in RPC Inc in Q1 2022 and held it in 2 quarters.
  • Alpha DNA Investment Management's RPC Inc position peaked at $1.25M in Q1 2022.
  • 229 funds tracked by Wall St. Rank held RPC Inc as of Q1 2023.

Based on Alpha DNA Investment Management's 13F filing for Q1 2023, filed 5 May 2023.